Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP3 | Q9NY33 | 3/20 | 0.58 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.56 |
| ▸ | ACE | P12821 | 2/20 | 0.55 |
| ▸ | REN | P00797 | 2/20 | 0.53 |
| ▸ | ANPEP | P15144 | 1/20 | 0.53 |
| ▸ | LNPEP | Q9UIQ6 | 1/20 | 0.53 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.52 |
| ▸ | OPRD1 | P41143 | 1/20 | 0.52 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.52 |
| ▸ | CMA1 | P23946 | 3/20 | 0.52 |
| ▸ | PSMB9 | P28065 | 1/20 | 0.51 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29638288 | 0.97 | DPP3 (0.58) | DPP3SLC6A2ACERENANPEP | |
| SCHEMBL29638290 | 0.94 | LNPEP (0.56) | DPP3SLC6A2ACERENANPEP | |
| SCHEMBL30945872 | 0.93 | DPP3 (0.62) | DPP3SLC6A2RENANPEPLNPEP | |
| SCHEMBL31016729 | 0.93 | SLC6A2 (0.59) | DPP3SLC6A2ACERENOPRM1 | |
| SCHEMBL29638293 | 0.93 | LNPEP (0.63) | SLC6A2RENANPEPLNPEP | |
| SCHEMBL29392664 | 0.90 | LNPEP (0.65) | DPP3SLC6A2RENANPEPLNPEP | |
| SCHEMBL29973755 | 0.90 | DPP3 (0.56) | DPP3SLC6A2RENANPEPLNPEP | |
| SCHEMBL30424040 | 0.89 | SLC6A2 (0.62) | DPP3SLC6A2ACERENOPRM1 | |
| SCHEMBL29637436 | 0.89 | SLC6A2 (0.60) | SLC6A2ACERENOPRM1OPRD1 | |
| SCHEMBL29466818 | 0.88 | SLC6A2 (0.64) | DPP3SLC6A2ACEANPEPLNPEP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-116574154-A | Cyclic peptide-lenalidomide PROTAC derivative, preparation method thereof and application thereof in anticancer drugs | 哈尔滨师范大学 | 2023-08-11 | — | — | CN | disclosed |